Skip to main content

Table 1 Demographic data and underlying diseases of intensive care unit patients with bronchoalveolar lavage lateral-flow-device test resultsa

From: Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients

  Present study population Graz Innsbruck Vienna Mannheim
Number of BALs/patients 149/133 70/61 51/49 18/13 10/10
Sex      
 Male 87 (65.4%) 45 (51.7%) 28 (32.2%) 6 (6.9%) 8 (9.2%)
 Female 46 (34.6%) 16 (34.8%) 21 (45.7%) 7 (15.2%) 2 (4.3%)
Median age (range) 60 (19 to 85) 66 (19 to 83) 58 (26 to 85) 59.5 (41 to 74) 55.5 (40 to 75)
Type of ICU admission (BALs)      
 Medical 121/149 (81.2%) 60/70 (85.7%) 35/51 (68.6%) 16/18 (88.9%) 10/10 (100%)
 Neurologic 6/149 (4%) 5/70 (2.9%) 1/51 (2%)
 Elective surgery 2/149 (1.3%) 1/51 (2%) 1/18 (5.6%)
 Emergency surgery 8/149 (5.4%) 4/70 (5.7%) 4/51 (7.8%)
 Trauma 12/149 (8.1%) 1/70 (1.4%) 10/51 (19.6%) 1/18 (5.6%)
Primary underlying disease (BALs)      
 Pulmonary disease 44/149 (29.5%) 21/70 (30%) 14/51 (27.5%) 6/18 (33.3%) 3/10 (30%)
 Heart disease 25/149 (16.8%) 17/70 (24.3%) 4/51 (7.8%) 4/18 (22.2%)
 Hematologic malignancies 19/149 (12.8%) 8/70 (11.4%) 3/51 (5.9%) 2/18 (11.1%) 6/10 (60%)
 Trauma 12/149 (8.1) 1/70 (1.4%) 10/51 (19.6%) 1/18 (5.6%)
 Neurologic disease 14/149 (9.4%) 11/70 (15.7%) 3/51 (5.9%)
 Gastrointestinal disease 13/149 (8.7%) 3/70 (4.3%) 7/51 (13.7%) 3/18 (16.7%)
 Metabolic disease 4/149 (2.7%) 1/70 (1.4%) 3/51 (5.9%)
 Other malignancies 5/149 (3.4%) 3/70 (4.3%) 2/51 (3.9%)
 Rheumatologic disease 4/149 (2.7%) 3/70 (4.3%) 1/10 (10%)
 Others 9/149 (6%) 2/70 (2.9%) 5/51 (9.8%) 2/18 (11.1%)
IPA classification      
 Proven IPA (BALs/patients) 4/2 3/1 1/1
 Probable IPA (BALs/patients) 16/14 6/6 8/7 2/1
 Possible IPA (BALs/patients) 21/20 6/5 6/6 9/9
 No IPA (BALs/patients) 108/97 58/50 37/36 13/11
  1. aBAL, Bronchoalveolar lavage; COPD, Chronic obstructive pulmonary disease; IPA, Invasive pulmonary aspergillosis.